Nuclear Morphological Characteristics in Breast Cancer: Correlation with Hormone Receptor and Human Epidermal Growth Factor Receptor 2

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/acp/volume-2021/3037993/figures/3037993.fig.004a.svgz" name="3037993.fig.004a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Histological characteristics of HR+/HER2- group (CNB, ×20)</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/acp/volume-2021/3037993/figures/3037993.fig.004b.svgz" name="3037993.fig.004b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Histological characteristics of HR+/HER2- group (CNB, ×40)</td></tr></table>

<div>(a, b) Histological characteristics of HR+/HER2- group (CNB, ×20 and ×40).</div>

Analytical Cellular Pathology

fig4

Figure 4

Figure 4: Nuclear Morphological Characteristics in Breast Cancer: Correlation with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 